-
Most Recent
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Other industries you might be interested in
Recent Biotech Stocks Articles
Southern Union Gassed as Winnebago Stalls
Midday stock action includes Winnebago (NYSE: WGO), Southern Union Company (NYSE: SUG), MediaMind Technologies (NASDAQ: MDMD).
Fidelity Select Pharmaceutical Mutual Fund Offers Diversified Drug Play
The Fidelity Select Pharmaceutical Portfolio offers a diversified group of big pharma stocks and biotech investments that give investors a way to play the entire sector easily.
Best Buy Rallies as Dollar Thrifty Gets a Flat
Trading midday sees action in Best Buy (NYSE: BBY), Kellogg (NYSE: K), Dollar Thrifty (NYSE: DTG) and FactSet Research (NYSE: FDS).
BioMimetic Has Suitors Lying in Wait
A key FDA OK could have the buyout offers rolling in.
Pharmaceutical Companies Hit New Highs, Solar Stocks New Lows
Solar stocks are among the investments hitting new 52 week lows today in the stock market as pharmaceutical companies hit new highs.
Bob Evans Rebounds, Abercrombie gets Rejected
Midday stock movers led by Bob Evans Farms (NASDAQ: BOBE), Ciena (NASDAQ: CIEN) and Abercrombie & Fitch (NYSE: ANF).
New AIDS Therapies May Shake Up Big Pharma Profits
Vaccines and transplants may usher in new players
Ziopharm Has Help With Deep Pockets
This biotech small-cap could soon be a cancer-drug player.
Selloff in Pharma United Therapeutics and Exelixis
Volume leaders in midday trading included Credicorp (NYSE: BAP), Lorillard (NYSE: LO), United Therapeutics Corp. (NASDAQ: UTHR).
Rubbermaid Bounced Out in Midday Trading
Stocks moving significantly at midday include Rubbermaid (NYSE: NWL), Arch Coal (NYSE: ACI), Quicksilver (NYSE: ZQK).
Biotech Royalty Paying 9% Dividend Yield
Technology permitting the deployment of animal-derived antibodies in human patients feeds PDL BioPharma’s rich royalty stream.
Could Legalized Pot Give Big Pharma a Much-Needed Boost?
Medical marijuana is big business where it's legalized, and if major pharmaceutical companies could get a share of the market they could see a big boost.
Johnson & Johnson Stock a Buy With Healthy Performance Ahead
After some recalls, Johnson & Johnson earnings are back on track. Along with a nice dividend, that makes it a good buy.
Clean Diesel and Tiffany Top Busy Stocks
Stocks seeing big jumps in volume this morning include Tiffany (NYSE: TIF), Clean Diesel Technology (NASDAQ: CDTI), hhgregg (NYSE: HGG).
Vertex vs. Merck in Hepatitis Drug Title Fight
All that's at stake is a $10 billion market.
Overseas Drug Test Trend May Cost AstraZeneca
The company's promising heart drug may face delays
